FDA approved device for facial skin tightening
- Trial ID:
- IRB-22-7948
- E. Victor Ross, M.D.
Inclusion Criteria
Patients must:- - Be between 18 and 75 years of age
- - Have clinically identifiable photodamage on facial skin, neck, or chest
- - Be willing and able to comply with all follow-up requirements
- - Meet all other eligibility requirements
Exclusion Criteria
Patients must not:- - Have active localized or systemic infections
- - Have a compromised ability for wound healing, such as: malnutrition, steroid use, history of collagen vascular disease, atrophic dermatitis, or immunologic abnormalities such as vitiligo
- - Be currently taking Accutane
- - Have a known allergy to lidocaine (numbing cream)
- - Have used topical steroids or retinoids within the last 3 months on treatment surfaces
- - Have a personal history of malignant melanoma, keloid scars, generalized psoriasis or systemic diseases that would preclude the use of topical anesthesia
- - Use cosmeceutical agents or topical agents during the course of the study, except as directed by study investigators
- - Be pregnant
- - Be exposed to excessive sun burn over the past 2 months
Additional Info
- The UltraClear Laser system is intended to improve photodamage by reducing fine lines, wrinkles, and acne scars and improving skin tone, appearance and texture.
Contact Info:
- Clinical Research Services
- CRSLeadership@scrippshealth.org